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Non-0157 Escherichia coli, isolated from Nono (fermented fresh cow milk) sampled from four major 
Nigerian cities, namely, Abuja, Benin City, Lagos and Onitsha were investigated for the presence shiga 
toxins (stx1 and stx2) genes using PCR technique and for their verotoxigenic potentials using tissue 
culture assay on Vero cells. The result of the investigation reveal that out of the total 800 samples 
collected, 268 (33%) had E. coli and out of this, 217 (81%) had non-0157 E. coli. Total number of non-
0157 E. coli isolated from the 217 samples was 503. Shiga toxin gene detection of the isolates revealed 
that 199(40%) had stx1 gene alone, 192 (38%) had stx2 gene alone, 4(1%) had both stx 1 and stx 2 
genes while 108 (21%) had none of the two genes. Tissue culture assay on Vero cells indicate that 
there is a strong relationship between the presence of stx genes and their degree of cytotoxic effect on 
vero cells as over 80% of the isolates without the genes exhibited weak cytotoxic effect whereas over 
80% of those with the stx genes exhibited varying degrees of cytotoxic effects ranging from strong to 
excellently strong. This study provides evidence of presence of non-0157 E. coli in our food system and 
can be of serious health challenge to consumers. 
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INTRODUCTION 
Escherichia coli are normal inhabitants of the 
gastrointestinal tract of animals and humans. 
Beneficial strains of E. coli typically colonize the 
infant’s gastrointestinal tract within a few hours 
after birth (Blackburn and McCarthy; 2000, 
Franzolin et al., 2005) andthe presence of the 
bacterial population in the intestine is reported 
to suppress the growth of other harmful bacteria 
and have been implicated in the synthesis of 
appreciable amounts of B vitamins (Nataro and 
Kaper, 1998). However, the organism has been 
implicated severally as a very important food 
borne pathogen (Hussein, 2007). Many strains 
of E. coli have infarct been identified as 
pathogens inducing serious gastrointestinal 
diseases and even causing death in humans 
(Kaper et al., 2004). Amongst these are those 
referred to as Shiga or Vero toxin producing E. 
coli.  
Bosilevac and Koohmaraie (2011) stated that 
more than 70 different serotypes of Shiga toxin-
producing Escherichia coli (STEC) are known 
that cause disease in humans. Illnesses caused 
by STEC ranges from mild diarrhoea to bloody 
diarrhoea to hemorrhagic colitis (HC) and 
haemolytic uremic syndrome (HUS). E. coli 
O157:H7 is the STEC strain most often 
associated with the most severe forms of 
disease and have extensively been studied 
(Scallan et al., 2011). However, numerous non-
O157 STEC isolates have also been linked to 
food- borne illnesses and outbreaks of disease 
(Johnson et al., 2006). 
Basically, most of the known E. coli outbreaks 
have been linked in one way or the other to 
food sources (Pradel et al., 2001, Solomon et. 
al., 2002, Hussein 2007). Fermented fresh cow 
milk (nono) is one of such food produce and it 
has been implicated severally as possible 
source of transmitting pathogenic 
microorganisms (Abdalla and El-Zubeir, 2006; 
Ekici et al., 2004; Adesiyun et al., 1995). Nono 
is an opaque white to milky liquid food drink 
prepared and sold predominantly by wives of 
the nomadic Hausa/Fulani herdsmen who 
control over 80% of Nigeria’s cattle production. 
It is a nutritiously rich food product whose 




consumption is known to transverse the 
Saharan tribes of West African sub-region 
extending to the inhabitants of the 
Mediterranean region and the Middle East 
(Ogbonna, 2011). Nono is reported to be 
nutritionally rich, containing  appreciable 
amount of essential amino acids, calcium, 
phosphorous and vitamins A, C, E and the B 
complex (Nebedum and Obiakor, 2007).  
Although other investigators have analysed the 
microbiological quality of Nono sold in Nigeria 
(Ogbonna, 2011; Obi and Ikenebomeh, 2007; 
Adesiyun et al., 1995), their reports have been 
of general nature and none have targeted the 
possibility of isolating this group of potentially 
dangerous pathogenic shiga- toxin producing E. 
coli from the food product.  
Consequent upon the above and the need to 
augment the scarce information on the 
organism in Nigeria, this research work was 
undertaken to isolate non- 0157 E. coli from 
fermented fresh cow milk (nono) sold in 
selected cities in Nigeria and thereafter do a 
shiga- toxin (stx) gene detection of all the 
isolates. Tissue culture assay was also 
performed to determine the toxigenic potentials 
of all the isolates on Vero cells. 
 
MATERIALS AND METHODS 
Fermented milk (nono) samples were collected 
randomly from different locations in four 
selected cities in Nigeria namely, Abuja, Benin 
City, Lagos and Onitsha. A total of 200 milk 
samples were collected from each city giving an 
overall total of 800 samples analysed. Sampling 
and screening was done between January, 
2014 and December, 2014. Samples were 
collected in duplicates at point of sales in sterile 
plastic containers, labelled and transported to 
the laboratory for immediate analysis.  
 
Isolation and Identification of E. coli Isolates 
The milk samples were homogenized in a 
sterile test tube by mixing with a sterile glass 
rod, thereafter 1 ml of the homogenate milk 
samples were suspended in 9 ml buffered 
peptone water. Serial dilutions of up to 10-5 
were then made and 1 ml of each was plated 
on Eosin methylene blue (EMB) agar and 
incubated at 37°C for 24 h. Pure cultures 
exhibiting typical dark colonies, and black 
centres with green metallic sheen which is 
characteristic of E. coli on EMB were then 
made in readiness for biochemical tests. 
Biochemical tests to confirm E. coli was done 
using the API 20E test strips and in accordance 
with the method described by Holt et al. (1994). 
 
Identification and Characterisation of Non-
0157:H7 E. coli  
Pure cultures of all positive E. coli were cultured 
on cefixim- tellurite sorbitol-MacConkey (CT-
SMAC) agar using the method of Vernozy-
Rozand (1997) and incubated at 37°C for 18 - 
24 h.  All sorbitol fermenters which showed light 
to dark pinkish colour on CT-SMCA suspected 
to be colon 
ies of non 0157 were selected and used for 
further analysis.  
 
Shiga toxin (stx) Gene analysis 
Molecular procedures using PCR technique 
targeting the stx 1 and stx 2 genes was done 
with primers (stx1; forward = 
CGCTGAATGTCATTCGCTCTGC; reverse = 
CGTGGTATAGCTACTGTCACC; stx2 ; forward 
= CTTCGGTATCCTATTCCCGG; reverse = 
CTGCTGTGACAGTGACAAAACGC) 
manufactured by Primerdesign Ltd, UK, 
according to method outlined by Blanco et al. 
(2003).  DNA extraction was done according to 
Sambrook and Russell, (2001). The mixture for 
the amplification of stx1 and stx2 genes 
consisted of 2.5μl of PCR buffer (10mM Tris–
HCl pH 9, 50mM KCl, and 0.1% Triton X-100), 
2.5mM MgCl2, 0.2mM of each dNTP, 1μM of 
each primer and 1.25U of Taq polymerase, in a 
final volume of 25μl. Amplification was done 
with a 96 well dual head Pelter Thermocycler 
(DNA engine Model PTC-200). The 
amplification conditions consisted of an initial 
denaturation step at 94°C for 4 min, and 30 
cycles of 94°C for 1 min (denaturation), 55°C 
for 1 min (annealing), and 72°C for 1 min 
(extension), and a final step at 72°C for 10 min. 
PCR products were analyzed by 
electrophoresis on 1% agarose gel and 
visualized by ethidium bromide staining in a UV 
trans-illuminator. All molecular work was done 
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at the Lahor research and diagnostic 
Laboratory, Benin City. 
 
Tissue Culture Assay for Verotoxin 
production 
Preparation of extract for tissue culture assay 
was done by first inoculating pure cultures of all 
test isolates maintained on nutrient agar slants 
in 5ml Trypticase soy broth (TSB) and 
incubated overnight at 37oC; 500µl of the 
inoculated Trypticase soy broth was then 
transferred onto 5ml brain heart infusion broth 
(BHIB) and incubated at 37oC for 24 h. Extract 
filtrate was obtained by first centrifuging 1ml of 
the incubated BHIB at 4000xg using a 
Gemmyco centrifuge model PLC-025 to reduce 
debris and aid filtration. The supernatant was 
then passed through a 0.20µm pore-size Titan 
Two 30mm diameter nylon membrane syringe 
filter (SMI-LabHut Ltd UK).  Sterility check was 
done on all filtrate by plating an aliquot of the 
filtrate on MacConkey agar and incubated 
overnight at 37oC. Plates showing no growth 
were considered sterile.   
The BHIB filtrates were screened for 
verocytotoxicity by using a modified method of 
Rahn et al. (1996).  Filtrate was used to cause 
swelling, rounding or dissemination of vero cells 
prepared by Passaging on monolayer in 96 well 
micro titre plates. Vero cells for the cell culture 
assay was prepared by trysinizing with 1X 
trypsin – EDTA and seeded in a 96 well flat 
bottom micro titre plate at 4 x 105/well and 
using  1% Glasgow Minimum Essential Medium 
(GMEM) with addition of Hepes buffer as the 
growth medium. Growth medium was replaced 
with fresh GMEM after aspiration before cells 
were infected with filtrate. Undiluted 100µl of 
the filtrate was transferred to the first well of 
each plate containing the vero cells and 1:2 
dilutions in each of the subsequent wells (i.e. 
100µl, 50µl, 25µl, 12.5µl, 6.25µl and 3.125 µl) 
were then done. The plates were incubated at 
37oC and examined for verotoxigenic activity 
after 3hrs, 6hrs, 12h 24h and 48h using an 
inverted microscope. Degree of verotoxigenic 
effect on each of the vero cells were noted and 
recorded after each examination. Picture of 
each well was taken before and after infection. 
Wells containing less than 25% cytotoxic effect 
after 48h end point were considered weak, 
greater than 25% but less than 50% fairly 
strong,  greater than 50% but less than 75% 
strong, greater than 75% but less than 90% 
very strong and greater than 90% excellently 
strong. Tissue culture assay was done at the 
Morbilic and Related Virus Laboratory, National 




The results of this study showed that out of the 
800 samples collected, 268 (33.50%) had E. 
coli Isolated from them and out of this number, 
217 had non- E. coli 0157(Table 1). In all, 503 
non -0157 E. coli were isolated with Onitsha 
recording the highest number of 164, while 
Abuja recorded the least number of isolates 
(98).   
 
Table 1: Prevalence and Number of non –0157 E. coli Isolated from Fermented Fresh Milk (Nono) 
 
City No. of 
samples 
analysed 
No.  of samples 
with E. coli (%)* 
No.  of samples 
with Non -0157 
E. coli (%)* 
No. of Non- 0157 
E. coli isolated 
Abuja 200 53(26.50) 42(21.0) 93 
Benin City 200 48(24.0) 41(20.5) 107 
Lagos 200 81(40.50) 64(32.0) 139 
Onitsha 200 86(43.0) 70(35.0) 164 
Total 800 268(33.50) 217(27.13) 503 
 *(%) based on number of samples analysed  
 
The result of the shiga toxin (stx) gene 
detection is presented in Table 2. The result 
showed that out of the 503 isolates analysed, 
199(40%) had stx1 gene alone, 192 (38%) had 




stx2 gene alone, 4(1%) had both stx 1 and stx 2 
genes while 108 (21%) had none of the two 
genes. 
 
Table 2: Shiga Toxin (stx) Gene Detection in non -0157 E. coli Isolates From Nono Sold in Nigeria  
 
City No. of Isolates 
tested  
No. with stx 1 
only  
No. with stx 2 
only 
No. with both 
stx 1 and stx 2 
No. with  no 
stx  gene 
Abuja  93 39 (42%) 36 (39%) 1(1%) 17 (18%) 
Benin 107 52 (48%) 35 (33%) Nil (0%) 20(19%) 
Lagos 139 41(30%) 62 (45%) 2 (1%) 34 (24%) 
Onitsha 164 67 (41%) 59 (36%) 1(1%) 37 (22%) 
Total 503 199 (40%) 192(38%) 4 (1%) 108 (21%) 
 
The result of the tissue culture assay on Vero 
cells presented in Table 3 revealed that those 
with no stx genes exhibited weak cytotoxic 
effect on Vero cells whereas those with the stx 
genes exhibited varying degrees of cytotoxic 
effects ranging from strong to excellently 
strong. Plates 1 to 3 show the picture, of the 
Vero cells indicating their state before and after 
infection with the toxin extracts. 
 










Shiga toxin  

































stx1 39 5 18 13 3 Nil 
Stx 2 36 2 11 21 2 Nil 














Benin  stx1 52 11 19 17 4 1 
Stx 2 35 5 17 15 4 2 














Lagos stx1 41 5 12 15 8 1 
Stx 2 62 8 25 36 9 4 














Onitsha stx1 67 7 29 24 5 2 
Stx 2 59 5 30 32 7 2 
















stx1 199 28 (14%) 78 (39%) 69 (35%) 20 (10%) 4 (2%) 
Stx 2 192 17 (9%) 71 (37%) 82 (43%) 16 (8%) 6 (3%) 





























Shiga toxin-producing Escherichia coli (STEC) 
are reported to be the leading cause of 
bacterial enteric infections worldwide (CDC, 
2009), and have been associated with food-
borne diseases which range from 
uncomplicated diarrhoea to haemolytic uremic 
syndrome (HUS). Fey et al., (2000) reported 
that several studies from United States, 
Canada, Europe, Argentina and Australia 
suggest that non-0157:H7 STEC infections are 
as prevalent or more so, than 0157:H7 
infections. The finding in this study which 
revealed that 81% of the E. coli isolated from 
nono was non- 0157:H7 confirmed the report of 
Johnson et al. (1996) who suggested that 
humans are more exposed to non- 0157:H7 
than their 0157: H7 strains. The high prevalent 
rate of E. coli isolated from nono could be an 
indication of the poor quality of water used or 
an indication of the unsanitary condition under 
which the products are produced. Obi and 
Ikenebomeh, (2007) reported the presence of 
pathogenic organisms in nono which included 
E. coli and other enteric bacteria after 
production. They suggested that nono be 
pasteurized after its fermentation before being 
sold to consumers so as to make it safe for 
consumption.  
The major virulent factor and a defining 
characteristic of Enterohemorrhagic E coli 
(EHEC) is shiga toxin (stx). Nataro and Kaper 
(1998) reported that this potent toxin is the 
major factor that leads to death and many other 
symptoms in patients infected with EHEC. 
O’Brien et al., (1992) reported that the stx 
family contain two major immunological non-
cross reactive groups called stx1 and stx 2, 
with a single EHEC strain possibly expressing 
stx 1 only, stx 2 only or both toxins. They 
posited that some EHEC strains even express 
multiple forms of stx1 genes.  Jackson et al. 
(1987) reported that the prototypical stx1 and 
stx2 toxins are known to have about 55 and 57 
% sequence identity in the A and B subunits, 
respectively, and that while stx1 is highly 
conserved, sequence variation exists within stx 
2. Shiga toxin gene detection of non- 0157 E. 
coli from Nono sold in Nigeria showed that 40% 
of the isolates carry the stx 1 gene alone while 
38% harbour the stx2 gene alone, only 4% 
harbour both stx1 and stx 2. Mathusa et al. 
(2011) reported that illnesses linked to STEC 
serotypes other than O157:H7 appear to be on 
the rise in the United States and worldwide, 
indicating that some of these organisms may 
be emerging pathogens. They noted that 
various virulence factors are involved in non-
O157 STEC pathogenicity with the combined 
presence of both eae and stx genes associated 
with enhanced virulence. They also noted that 
although substantial progress has been made, 
a practical method of STEC detection has yet 
to be validated making the rapid detection of 
the organism difficult. 
The use of vero cells to confirm verotoxin or 
shiga toxin production in microorganisms have 
been indicated by various authors 
(Konowalchuck et al., 1977; Karmali et al., 
1983; O’Brien et. al., 1983; Riley et.al., 1983; 
Johnson et. al., 1983). Since it was first 
observed by Konowalchuck et al. (1977), 
cytotoxicity to vero cell line has remained a 
‘’gold standard’’ for confirming putative shiga 
toxin producing isolates, especially as it has 
been proven that vero cells have a high 
concentration of globotriaosylceramide (Gb3) 
and globotetraosylceramide (Gb4) toxin-binding 
   
Plate 1: Uninfected Vero Cells still 
intact at both beginning and end of 
experiment 
Plate 2: Infected Cells Exhibiting 
rounding and clumping after 
infection with toxin 
Plate 3: Infected Vero cells showing very 
high degrees of cytotoxic effect on it with 
the Vero cells detached and completely 
being eroded at the end of experiment  
 




receptors in their plasma membranes and will 
detect all variants of verotoxins (Mora et al., 
2004).  Tissue culture assay to determine their 
pathogenic potential on vero cells showed that 
74% of the isolates harbouring only stx 1 
elicited strong cytotoxic effect on vero cells and 
80% of isolates harbouring only stx 2 having 
between strong and very strong cytotoxic effect 
on vero cells. Few of the isolates harbouring stx 
1 and stx 2 alone also showed excellent 
cytotoxic effect on vero cells. Those isolates 
with stx1 and stx2 though very few, elicited very 
very strong cytotoxic effect on vero cells. 
Majority of the isolates without stx elicited weak 
cytotoxic effect on vero cells. These results 
indicate a strong relationship between the 
presence of stx and the degree of cytotoxic 
effect on vero cells, supporting the view of 
Gyles (2007) that shiga toxin is the critical 
factor in STEC diseases. The fact that some 
isolates not harbouring the stx gene showed 
some level of cytotoxic effect indicates that 
other virulence factors could be present in the 
E coli. Nataro and Kaper (1998) gave a detailed 
review of these virulence factors which include 
the presence of intestinal adherence factors 
and haemolysin encoding genes.  
Conclusively, this study not only established 
the presence of non 0157:H7 E. coli in Nono 
sold in Nigeria, but it also showed that Nono 
could be a potential public health hazard.   This 
study also provides a baseline data on non 
0157 STEC infection in Nigeria. Effort should 
therefore be made by local and National health 
authorities to properly monitor the way Nono 
and other related food products are processed 
and sold. It is recommended that proper 
surveillance strategies should also be put in 
place aimed at identifying actual causative 
agents of food borne infections reported in the 
hospitals, especially those reported from the 
rural areas where these food products are 
mostly consumed.  
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